Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 226-394-6 | CAS number: 5392-40-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Neurotoxicity
Administrative data
Description of key information
Key value for chemical safety assessment
Additional information
Neurobehavioral testing was performed in groups of male mice or rats to detect short-term effects occurring within up to 60 min after intraperitoneal or oral exposure. In mice, intraperitoneal doses ranged from 5-200 mg/kg bw and oral doses were 50 or 100 mg/kg bw. Rats were exposed to a single dose of 100 mg/kg bw, either by intraperitoneal or oral application. The tests included observation of behaviour in the open field test, rota rod performance, spontaneous motor activity, and pentobarbital sleeping time, covering endpoints as locomotor activity, muscle relaxation, anxiolytic activity, and barbiturate induced sleeping behaviour.
In mice, a central nervous depressant effect of citral was indicated after intraperitoneal application starting at 50 mg/kg bw for spontaneous motor activity and in the elevated plus maze test (Carlini 1986; Do Vale 2002), but no effects were found after oral application up to the high dose of 100 mg/kg bw (Carlini 1986).
Furthermore, intraperitioneal application of 100 mg/kg citral in rats resulted in central nervous depressant effects but no effects were found after oral application of this dose to rats (Carlini 1986).
In summary, after oral application no neurological effects were found up to the highest tested dose (100 mg/kg bw) , both in mice and in rats.
Intraperitoneal application represents a mode of exposure which is not relevant for human exposure. The dose is delivered into the body independent of absorption from the gastrointestinal tract and circumventing first-pass metabolism in the liver. Consequently, the intraperitoneal effects observed are not relevant for human risk assessment.
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
